11:14 AM EST - BioVaxys Technology Corp. : Announces that James Tartaglia, PhD, a former top R&D and commercial development executive with Sanofi Vaccines, has been appointed to the BioVaxys Board of Directors. Dr. Tartaglia fills a vacancy created by the resignation of Director Anthony Dutton, who has stepped down. BioVaxys Technology Corp.
shares C.BIOV are trading -$0.03 at $0.25.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=BIOV%3ACC&qmodStoryID=5248318769814169
